Gretchen A. Repasky

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

Tea Pemovska, Eric F. Johnson, Mika Kontro et al. · Nature · 2015 · 235 citations

Molecular Pharmacology, Drug Target, Medicine +6

Involvement of Ras Activation in Human Breast Cancer Cell Signaling, Invasion, and Anoikis

Lynn B. Eckert, Gretchen A. Repasky, Aylin S. Ülkü et al. · Cancer Research · 2004 · 203 citations

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

Jing Tang, Ziaurrehman Tanoli, Balaguru Ravikumar et al. · Cell chemical biology · 2017 · 166 citations · Full text

Characterization of RERG: An Estrogen‐Regulated Tumor Suppressor Gene

Megan D. Key, Douglas Andres, Channing J. Der et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2006 · 20 citations

Medicine, Breast Cancer, Tumor Suppressor +4

The higher frequency of IgA deficiency among Swedish twins is not explained by HLA haplotypes

Marcel Frankowiack, R-M Kovanen, Gretchen A. Repasky et al. · Genes and Immunity · 2015 · 17 citations

Histocompatibility, Haplotype Determination, Allergy +11